BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31084855)

  • 1. Arrhythmias due to Inherited and Acquired Abnormalities of Ventricular Repolarization.
    Locati ET; Bagliani G; Cecchi F; Johny H; Lunati M; Pappone C
    Card Electrophysiol Clin; 2019 Jun; 11(2):345-362. PubMed ID: 31084855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K; Sredniawa B; Pasyk S
    Przegl Lek; 2002; 59(7):523-6. PubMed ID: 12516242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogeneities of ventricular repolarization and vulnerability to arrhythmia. How to detect them with noninvasive methods?].
    De Ambroggi L
    Cardiologia; 1999 Apr; 44(4):355-60. PubMed ID: 10371787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of early repolarization in short QT syndrome.
    Watanabe H; Makiyama T; Koyama T; Kannankeril PJ; Seto S; Okamura K; Oda H; Itoh H; Okada M; Tanabe N; Yagihara N; Kamakura S; Horie M; Aizawa Y; Shimizu W
    Heart Rhythm; 2010 May; 7(5):647-52. PubMed ID: 20206319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.
    Qiu B; Wang Y; Li C; Guo H; Xu Y
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Benign" early repolarization versus malignant early abnormalities: clinical-electrocardiographic distinction and genetic basis.
    Pérez-Riera AR; Abreu LC; Yanowitz F; Barros RB; Femenía F; McIntyre WF; Baranchuk A
    Cardiol J; 2012; 19(4):337-46. PubMed ID: 22825893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of T-wave alternans.
    Armoundas AA; Cohen RJ
    Card Electrophysiol Rev; 1997; 1(3):390-4. PubMed ID: 11541510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of ventricular arrhythmias in the long QT syndrome: on hermeneutics.
    El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):973-6. PubMed ID: 11513452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal cardiac repolarization abnormalities.
    Zhao H; Strasburger JF; Cuneo BF; Wakai RT
    Am J Cardiol; 2006 Aug; 98(4):491-6. PubMed ID: 16893703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed repolarization syndrome.
    Schweitzer P; Mark H
    Am J Med; 1983 Sep; 75(3):393-401. PubMed ID: 6614027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation.
    Justo F; Fuller H; Nearing BD; Rajamani S; Belardinelli L; Verrier RL
    Heart Rhythm; 2016 Sep; 13(9):1860-7. PubMed ID: 27317981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ventricular arrhythmias in ion channel diseases].
    Wolpert C; Vogel M; Nagel C; Herrera-Siklody C; Rüb N
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):169-176. PubMed ID: 28534204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between repolarization parameters and serum electrolyte levels in patients with J wave syndromes.
    Sato N; Sasaki R; Imahashi M; Ito E; Saito K; Kubota H; Talib AK; Sakamoto N; Akasaka K; Saijo Y; Kawamura Y; Fujii S; Hasebe N
    Magnes Res; 2015; 28(1):1-13. PubMed ID: 25967879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?
    Antzelevitch C
    J Electrocardiol; 2004; 37 Suppl():15-24. PubMed ID: 15534788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in repolarization dynamicity and the assessment of the arrhythmic risk.
    Maison-Blanche P; Coumel P
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2614-24. PubMed ID: 9358509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.